Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of linagliptin vs glimepiride added to metformin on postprandial beta cell function and oxidative stress in type 2 diabetes
2012-000179-17Phase 4Completed
- Sponsor
- IKFE
- Start
- Feb 2012
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of linagliptin and glimepiride in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by IKFE. Primary endpoints: Postprandial increase in intact proinsulin levels (peak) and Postprandial increase in intact proinsulin levels (AUC). Started Feb 2012; status: completed.
02
Drugs
linagliptinglimepiride
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2012-000179-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000179-17.